Full View

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor X a inhibitor, in healthy subjects

C Frost, S Nepal, J Wang, A Schuster… - British journal of …, 2013 - Wiley Online Library
Aim Apixaban is an oral factor X a inhibitor approved for stroke prevention in atrial fibrillation
and thromboprophylaxis in patients who have undergone elective hip or knee replacement …
被引用次数：331 相关文章

[引用][C] Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

C Frost, S Nepal, J Wang, A Schuster, Z Yu… - British Journal of …, 2013 - elibrary.ru

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects.

C Frost, S Nepal, J Wang, A Schuster… - British Journal of …, 2013 - europepmc.org
Aim Apixaban is an oral factor Xa inhibitor approved for stroke prevention in atrial fibrillation
and thromboprophylaxis in patients who have undergone elective hip or knee replacement …
[HTML] nih.gov

[HTML][HTML] Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

C Frost, S Nepal, J Wang, A Schuster… - British Journal of …, 2013 - ncbi.nlm.nih.gov
Aim Apixaban is an oral factor Xa inhibitor approved for stroke prevention in atrial fibrillation
and thromboprophylaxis in patients who have undergone elective hip or knee replacement …

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

C Frost, S Nepal, J Wang, A Schuster, W Byon… - 2013 - pubmed.ncbi.nlm.nih.gov
Aim Apixaban is an oral factor Xa inhibitor approved for stroke prevention in atrial fibrillation
and thromboprophylaxis in patients who have undergone elective hip or knee replacement …

[引用][C] Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor X a inhibitor, in healthy subjects

C Frost, S Nepal, J Wang, A Schuster, W Byon… - British Journal of …, 2013 - cir.nii.ac.jp
Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor
<scp>X</scp> a inhibitor, in healthy subjects | CiNii Research CiNii 国立情報学研究所 学術 …

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor X a inhibitor, in healthy subjects

C Frost, S Nepal, J Wang, A Schuster, W Byon… - British Journal of Clinical …, 2013 - infona.pl
Aim Apixaban is an oral factor X a inhibitor approved for stroke prevention in atrial fibrillation
and thromboprophylaxis in patients who have undergone elective hip or knee replacement …